比例辅助通气缩短机械通气时间的随机对照试验研究方案:PROMIZING研究
PROMIZING是一项多中心随机对照试验,计划纳入约20个中心的急性呼吸衰竭患者,比较比例辅助通气(PAV+)与压力支持通气(PSV)对成功拔管时间的影响。患者需耐受短期PSV试验且不符合常规撤机标准、或失败2分钟零持续气道正压试验、或失败自主呼吸试验后,按1:1随机分组。主要结局为拔管时间,次要结局包括无呼吸机天数等。
要点
- PAV+按患者努力成比例送气,增益可由临床医生调节以维持呼吸努力在正常范围。
- 与PSV相比,PAV+短期生理获益包括更好的人机同步性和对通气需求变化更生理性的反应。
- 研究针对急性呼吸衰竭患者,比较PAV+与PSV的成功拔管时间,两臂撤机过程相同。
核心结论
- 该研究旨在确定对于急性呼吸衰竭患者,PAV+通气是否比PSV通气获得更短的成功拔管时间。
研究设计与样本
- 多中心随机对照试验,计划涉及约20个中心,分布在多个大洲。
- 开放标签设计,患者按1:1比例随机分配至PSV或PAV+。
- 入选患者须耐受短期PSV试验,且依次满足以下之一:不符合常规撤机标准、失败2分钟零持续气道正压试验(使用浅快呼吸指数)、或失败自主呼吸试验。
- PAV+根据目标肌肉压设定,两臂撤机过程相同。
- 主要结局为拔管时间,同时测量无呼吸机天数和其他结局。
局限性
- 原文指出,迄今尚无针对最可能从干预中获益的困难撤机患者人群、或采用一致时机实施PAV+的把握度充分的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proportional assist ventilation with load-adjustable gain factors (PAV+) is a mechanical ventilation mode that delivers assistance to breathe in proportion to the patient's effort. The proportional assistance, called the gain, can be adjusted by the clinician to maintain the patient's respiratory effort or workload within a normal range. Short-term and physiological benefits of this mode compared to pressure support ventilation (PSV) include better patient-ventilator synchrony and a more physiological response to changes in ventilatory demand. METHODS: The objective of this multi-centre randomized controlled trial (RCT) is to determine if, for patients with acute respiratory failure, ventilation with PAV+ will result in a shorter time to successful extubation than with PSV. This multi-centre open-label clinical trial plans to involve approximately 20 sites in several continents. Once eligibility is determined, patients must tolerate a short-term PSV trial and either (1) not meet general weaning criteria or (2) fail a 2-min Zero Continuous Positive Airway Pressure (CPAP) Trial using the rapid shallow breathing index, or (3) fail a spontaneous breathing trial (SBT), in this sequence. Then, participants in this study will be randomized to either PSV or PAV+ in a 1:1 ratio. PAV+ will be set according to a target of muscular pressure. The weaning process will be identical in the two arms. Time to liberation will be the primary outcome; ventilator-free days and other outcomes will be measured. DISCUSSION: Meta-analyses comparing PAV+ to PSV suggest PAV+ may benefit patients and decrease healthcare costs but no powered study to date has targeted the difficult to wean patient population most likely to benefit from the intervention, or used consistent timing for the implementation of PAV+. Our enrolment strategy, primary outcome measure, and liberation approaches may be useful for studying mechanical ventilation and weaning and can offer important results for patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT02447692 . Prospectively registered on May 19, 2015.
引用
- Bosma KJ, Martin CM, Burns KEA, et al. Study protocol for a randomized controlled trial of Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: the PROMIZING study. Trials. 2023. PMID: 36973743. doi:10.1186/s13063-023-07163-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。